Review
doi: 10.1038/nrg2006.
Strategies for silencing human disease using RNA interference
Affiliations
- PMID: 17304245
- DOI: 10.1038/nrg2006
Item in Clipboard
Review
Strategies for silencing human disease using RNA interference
Nat Rev Genet.
2007 Mar.
Abstract
Since the first description of RNA interference (RNAi) in animals less than a decade ago, there has been rapid progress towards its use as a therapeutic modality against human diseases. Advances in our understanding of the mechanisms of RNAi and studies of RNAi in vivo indicate that RNAi-based therapies might soon provide a powerful new arsenal against pathogens and diseases for which treatment options are currently limited. Recent findings have highlighted both promise and challenges in using RNAi for therapeutic applications. Design and delivery strategies for RNAi effector molecules must be carefully considered to address safety concerns and to ensure effective, successful treatment of human diseases.
Similar articles
-
Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.Gene. 2014 Apr 1;538(2):217-27. doi: 10.1016/j.gene.2013.12.019. Epub 2014 Jan 7. Gene. 2014. PMID: 24406620 Review.
-
RNAi therapeutics: principles, prospects and challenges.Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):75-86. doi: 10.1016/j.addr.2007.03.005. Epub 2007 Mar 16. Adv Drug Deliv Rev. 2007. PMID: 17449137 Free PMC article. Review.
-
Therapeutic siRNA: principles, challenges, and strategies.Yale J Biol Med. 2012 Jun;85(2):187-200. Epub 2012 Jun 25. Yale J Biol Med. 2012. PMID: 22737048 Free PMC article. Review.
-
An update on RNA interference-mediated gene silencing in cancer therapy.Expert Opin Biol Ther. 2014 Nov;14(11):1581-92. doi: 10.1517/14712598.2014.935334. Epub 2014 Jul 10. Expert Opin Biol Ther. 2014. PMID: 25010067 Review.
-
RNAi and miRNA in viral infections and cancers.Asian Pac J Cancer Prev. 2013;14(12):7045-56. doi: 10.7314/apjcp.2013.14.12.7045. Asian Pac J Cancer Prev. 2013. PMID: 24460249 Review.
Cited by
-
Gene therapy with caspase-3 small interfering RNA-nanoparticles is neuroprotective after optic nerve damage.Neural Regen Res. 2021 Dec;16(12):2534-2541. doi: 10.4103/1673-5374.313068. Neural Regen Res. 2021. PMID: 33907045 Free PMC article.
-
Baculovirus-mediated gene delivery and RNAi applications.Viruses. 2015 Apr 22;7(4):2099-125. doi: 10.3390/v7042099. Viruses. 2015. PMID: 25912715 Free PMC article. Review.
-
Production of cloned pigs with targeted attenuation of gene expression.PLoS One. 2013 May 30;8(5):e64613. doi: 10.1371/journal.pone.0064613. Print 2013. PLoS One. 2013. PMID: 23737990 Free PMC article.
-
Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.Int J Nanomedicine. 2013;8:2101-17. doi: 10.2147/IJN.S42440. Epub 2013 Jun 5. Int J Nanomedicine. 2013. PMID: 23766646 Free PMC article.
-
A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.Int J Nanomedicine. 2012;7:3837-49. doi: 10.2147/IJN.S32676. Epub 2012 Jul 18. Int J Nanomedicine. 2012. PMID: 22888238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
